Act | West Countries' FY23 Work Plans
The FY23 Work Plan each country covers October 1, 2022 - September 30, 2023, the fifth year of the program. The fifth-year work plan continues to build on the previous achievements of the program and consider lessons learned. It aims to achieve the following three intermediate results (IRs):
IR1: Increased mass drug administration (MDA) coverage among at-risk populations in endemic countries
IR2: Strengthened country environment for implementation and management of national NTD programs (NTDPs)
IR3: Sustained MDA coverage among at-risk populations in endemic countries
Act West FY23 Workplan-Benin.pdf
Act West FY23 Workplan-Burkina Faso.pdf
Act West FY23 Workplan-Cameroon.pdf
Act West FY23 Workplan-Cote d'Ivoire.pdf
Act West FY23 Workplan-Ghana.pdf
Act West FY23 Workplan-Guinea.pdf
Act West FY23 Workplan-Mali.pdf
Act West FY23 Workplan-Niger.pdf
Act West FY23 Workplan-Senegal.pdf
Type
Work Plan
Year of publication
Disease
All Preventive Chemotherapy NTDs
Country
All Countries, Benin, Burkina Faso, Cameroon, Cote d’Ivoire, Ghana, Guinea, Mali, Niger, Senegal, Sierra Leone, Togo
Focus Areas
Mass Drug Administration (MDA), MDA implementation, Community outreach, Drug procurement & supply chain support, Cross-border initiatives, Annual training for MDA, Support for NTD Sustainability, Advocacy and policies, Cross-sector collaboration, NTD governance, Strategic health information, NTD Capacity Building, Monitoring, Evaluation, Research, Learning and Adapting (MERLA), Disease-specific assessments, post-treatment surveillance, and related training, Disease & morbidity mapping & assessment, Learning & quality improvement, Data for decision-making, Operational research, Dossier development
Partners
AIM Initiative, Deloitte, FHI360, HDI, Helen Keller International, World Vision